Trial shows a single dose of an experimental therapy reduces lipoprotein(a) by more than 94% for nearly a year
Findings from a Phase I trial reported by a Cleveland Clinic physician show that a single dose of an experimental therapy produced greater than 94% reductions in blood levels of lipoprotein(a), a key driver of heart disease ...
Nov 13, 2023
0
96